Innovita Biological Technology Co., Ltd. Stock
Equities
688253
CNE100005Q14
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
41.5 CNY | -1.43% | -4.82% | +65.93% |
Apr. 15 | Innovita Biological Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 12 | China stocks track Asian markets lower on rate concerns | RE |
Sales 2022 | 447M 61.75M | Sales 2023 | 478M 66.1M | Capitalization | 3.4B 471M |
---|---|---|---|---|---|
Net income 2022 | 151M 20.88M | Net income 2023 | 174M 24.06M | EV / Sales 2022 | 3.94 x |
Net cash position 2022 | 1.48B 205M | Net cash position 2023 | 1.69B 234M | EV / Sales 2023 | 3.57 x |
P/E ratio 2022 |
19.2
x | P/E ratio 2023 |
19.5
x | Employees | 404 |
Yield 2022 |
0.7% | Yield 2023 |
1.6% | Free-Float | 36.84% |
1 day | -1.43% | ||
1 week | -4.82% | ||
Current month | +14.23% | ||
1 month | +33.57% | ||
3 months | +35.27% | ||
6 months | +67.81% | ||
Current year | +65.93% |
Managers | Title | Age | Since |
---|---|---|---|
Xiu Jie Zhang
FOU | Founder | 53 | 06-02-05 |
Xiu Juan Zhao
DFI | Director of Finance/CFO | 50 | 16-09-30 |
Song Ling Li
CHM | Chairman | 43 | 13-09-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Yi Lin
BRD | Director/Board Member | 55 | 19-11-30 |
Guan Mu Dong
BRD | Director/Board Member | 72 | 20-11-08 |
Feng Guang Ye
CHM | Chairman | 39 | 15-10-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-13 | 41.5 | -1.43% | 3,368,440 |
24-05-10 | 42.1 | -5.96% | 4,975,238 |
24-05-09 | 44.77 | +0.47% | 4,410,939 |
24-05-08 | 44.56 | -4.50% | 6,155,086 |
24-05-07 | 46.66 | +7.02% | 8,738,694 |
End-of-day quote Shanghai S.E., May 12, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
+65.93% | 793M | |
-3.58% | 12.64B | |
-1.48% | 8.46B | |
+8.70% | 5.66B | |
+25.61% | 5.27B | |
-4.58% | 4.49B | |
-51.80% | 3.11B | |
+16.25% | 2.87B | |
+30.25% | 2.31B | |
-4.08% | 1.89B |
- Stock Market
- Equities
- 688253 Stock